Side-by-Side Comparison
JNJ vs ABBV
Diversified pharma. Compare price, valuation, growth, profitability, and balance-sheet quality — all in one view.
JNJ wins 5·ABBV wins 5·Updated daily
JNJ
Johnson & Johnson
Healthcare
$230.42
+274.68%
ABBV
AbbVie Inc.
Healthcare
$208.50
+30.79%
Metric
JNJ
ABBV
Price
Last traded price
$230.42
$208.50
Day Change
Latest session move
+274.68%
+30.79%
Market Cap
Total equity value
$554.67B
$368.38B
P/E (TTM)
Trailing earnings multiple
26.7
102.2
Forward P/E
Forward earnings multiple
18.1
12.9
P/S
Price-to-sales ratio
5.76
5.86
EV/EBITDA
Enterprise value to EBITDA
16.7
14.4
Revenue (TTM)
Trailing twelve-month revenue
$96.36B
$62.82B
Revenue Growth
Year-over-year revenue growth
990.0%
1240.0%
Profit Margin
Net income as % of revenue
2183.4%
578.6%
Operating Margin
Operating income as % of revenue
2740.8%
3215.6%
Return on Equity
Net income as % of equity
2641.6%
—
Debt / Equity
Total debt vs equity
67.73
—
Free Cash Flow
Trailing FCF
$12.51B
$20.81B
Dividend Yield
Annualized yield
100.00%
100.00%
Beta
Volatility vs market
0.26
0.31
52W High
12-month high
$251.71
$244.81
52W Low
12-month low
$146.12
$176.57
Highlighted values indicate the better reading for that metric, where direction is unambiguous. Lower is generally better for valuation multiples and leverage; higher is better for growth, margin, and cash-flow metrics. Educational data only, not investment advice.
Go deeper than a side-by-side.
Add JNJ and ABBV to your Meridian watchlist for live alerts, AI-driven setups, and full earnings coverage.